Bio-Rad Laboratories IncClass A
D

BIO

369.30
USD
-1.06
(-0.29%)
Market Open
Last updated: · Delayed 15 min
Volume
1,388
EPS
9
Div Yield
-
P/E
10
Market Cap
9,931,564,589
Signals
هشام منسي
هشام منسي
11 months ago
buy
BIOBio-Rad Laboratories IncClass A @323
2025-11-25 07:13
BIO@323 Chart
Profit
-1,154.00
USD
-7.15%
More
Related Instruments

Title: Bio/Rad Laboratories IncClass A

Sector: Healthcare
Industry: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Common questions about Bio-Rad Laboratories IncClass A stock